№ US20260000675A1発明
審査中COMBINATION THERAPY FOR PREVENTING OR TREATING OBESITY
COMBINATION THERAPY FOR PREVENTING OR TREATING OBESITY
The present invention relates to a combination therapy for effectively preventing or treating obesity. More specifically, the objective of the present invention is to effectively prevent or treat obesity through a synergistic effect obtained when a melanocortin-4 receptor (MC4R) agonist and a glucagon-like peptide-1 (GLP-1) receptor agonist are administered in combination.
❖LG CHEM, LTD.Hee Dong Park; Su Jin Yeo; Hye Kyeong Hwang§ 2/9 請求項A61K 31/5377, A61K 31/4545, A61K 38/26 +210